American State Bank (Iowa)’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-500
Closed -$25.7K – 140
2023
Q4
$25.7K Hold
500
– – 0.02% 234
2023
Q3
$29K Hold
500
– – 0.02% 223
2023
Q2
$32K Hold
500
– – 0.02% 223
2023
Q1
$34.7K Hold
500
– – 0.03% 219
2022
Q4
$36K Hold
500
– – 0.03% 217
2022
Q3
$35.5K Hold
500
– – 0.03% 211
2022
Q2
$38.5K Hold
500
– – 0.03% 207
2022
Q1
$36.5K Hold
500
– – 0.03% 212
2021
Q4
$31.2K Hold
500
– – 0.02% 217
2021
Q3
$29.6K Hold
500
– – 0.02% 219
2021
Q2
$33.4K Hold
500
– – 0.03% 219
2021
Q1
$31.6K Hold
500
– – 0.03% 215
2020
Q4
$31K Buy
+500
New +$30.7K 0.03% 207

Other funds holding BMY

American State Bank (Iowa)'s BMY Position: Q1 2024 in Review

American State Bank (Iowa) sold out of Bristol-Myers Squibb (BMY) in Q1 2024, closing a stake of 500 shares — an estimated $25.7K sold.

American State Bank (Iowa) first reported a position in BMY in Q4 2020 and held it in 13 quarters. The position peaked at $38.5K in Q2 2022. 2,339 funds tracked by Wall St. Rank hold BMY as of Q1 2024.

  • American State Bank (Iowa) reported no remaining Bristol-Myers Squibb position as of Q1 2024 after selling out during the quarter.
  • American State Bank (Iowa) sold 500 Bristol-Myers Squibb shares in Q1 2024, an estimated $25.7K.
  • American State Bank (Iowa) first reported a position in Bristol-Myers Squibb in Q4 2020 and held it in 13 quarters.
  • American State Bank (Iowa)'s Bristol-Myers Squibb position peaked at $38.5K in Q2 2022.
  • 2,339 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2024.

Based on American State Bank (Iowa)'s 13F filing for Q1 2024, filed 14 Apr 2026.